{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/153957345",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1327154972"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#153957345",
  "code": "2A90.3",
  "source": "http://id.who.int/icd/entity/153957345",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/153957345/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Aggressive NK cell leukaemia"
  },
  "definition": {
    "@language": "en",
    "@value": "A rare, highly aggressive, Epstein-Barr virus-associated leukaemia, also known as aggressive NK-cell leukaemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterised by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Aggressive NK cell leukaemia"
      }
    }
  ]
}